Sleep Apnea Diagnostics Market Worth $ 685.66 Million by 2028

Sleep Apnea Diagnostics Market to Grow at a CAGR of 5.4% to reach US$ 685.66 Million from 2021 to 2028

NEW YORK, UNITED STATES, November 30, 2021 /EINPresswire.com/ -- According to our latest study on “Sleep Apnea Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and End User,” the market is projected to reach US$ 685.66 million by 2028 from US$ 473.95 million in 2021; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. Factors such as increased sleep apnea prevalence, technological developments, and rising geriatric population are boosting the sleep apnea diagnostics market growth. However, the high cost of diagnosis, and challenges in medical device industry hamper the growth of the market.

Strategic Insights

Report Coverage Details
Market Size Value in - US$ 473.95 million in 2021
Market Size Value by - US$ 685.66 million by 2028
Growth rate - CAGR of 5.4% from 2021 to 2028
Forecast Period - 2021-2028
Base Year - 2021
No. of Pages - 166
No. Tables - 84
No. of Charts & Figures - 73
Historical data available - Yes
Segments covered - Product, End User, and Geography
Regional scope - North America; Europe; Asia Pacific; Latin America; MEA
Country scope - US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverage - Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Request for sample PDF Copy of Sleep Apnea Diagnostics Market Study at: https://www.theinsightpartners.com/sample/TIPRE00016809/

Sleep apneais a common type of sleep disorder that happens when an individual is having trouble in breathing during sleep where breathing repeatedly stops and starts. Sleep apnea devices are primarily provided as diagnostic and therapeutic devices in order to treat obstructive sleep apnea syndrome, central sleep apnea syndrome and complex sleep apnea syndrome. Continuous positive airway pressure is widely recommended device to treat obstructive sleep apnea.

Increased Prevalence of Sleep Apnea Boosts Sleep Apnea Diagnostics Market Growth

Obstructive sleep apnea (OSA) is a common disorder, characterized by the repetitive, complete or partial closure of the upper airway during sleep. This airway is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in the form of impairment of daytime functioning and degraded quality of life. As per recent controlled trials, oral appliances are up to 50.0% efficient in controlling the OSA among patients, including severe cases.

According to a survey conducted by Needham & Company, an investment firm, over one-third of OSA tests were conducted in patients' homes in 2018, up from 15% in 2013. As a result, companies are concentrating their efforts on the development of home-care sleep apnea equipment. In June 2019, the FDA approved Itamar Medical, an Israel-based business, for a disposable home sleep apnea test. ResApp (Australia), a firm that develops smartphone applications for the diagnosis and management of respiratory disorders, has launched SleepCheck, an at-home screening app for the OSA.

Due to the rising use of the polysomnography(PSG) device in the various regions, the need for improved and technologically advanced PSG devices for the diagnosis of OSA has surged substantially, thus driving the global sleep apnea diagnostics market.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns.

Get the Latest COVID-19 Analysis on Sleep Apnea Diagnostics Market at: https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00016809

The sleep apnea diagnostics market, based on product, is segmented into polysomnography (PSG) device, home sleep testing devices, oximeter, actigraphy monitoring device, sleep apnea screening device. The oximeter segment is further segmented into fingertip oximeter, handheld oximeter, wrist-worn oximeter, and table-top oximeter.

The PSG device segment is expected to hold the largest share of ~59.09% of the sleep apnea diagnostics market in 2021. Based on End User, the sleep apnea diagnostics market has been segmented into hospitals and sleep laboratories, and home care settings. The hospitals and sleep laboratories segment is likely to account for a larger market share in 2021. However, the home care settings segment is expected to register a higher CAGR in the market during the forecast period.

PSG is the sleep diagnostic test carried out in hospitals and sleep centers to study the sleep disorders. It records heart cycle, breathing, brain waves, legs movement, and blood oxygen levels. The night sleep pattern is recorded, and it is also employed occasionally to record the daytime sleep habits. The diagnosis process focuses on nonrapid eye movement (NREM) as the first stage. During this stage, the brain waves are calculated by electroencephalography (EEG). Later to this stage, rapid eye movement is checked after one or two hours. The PSG monitors the sleep stages and the cycle during sleep or the disruption of the sleep.

Sleep Apnea Diagnostics Market : Competitive Landscape and Key Developments

Drive DeVilbiss International, ResMed Inc, Nihon Kohden Corporation, SOMNOmedics GmbH, Cleveland Medical Devices Inc, Koninklijke Philips N.V., Cadwell Industries Inc, Natus Medical Incorporated, Itamar Medical Ltd., and Compumedics Limited are among the leading companies operating in the sleep apnea diagnostics market.

Order a Copy of Sleep Apnea Diagnostics Marke Size, Strategies and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00016809/

Browse Related Reports and get Sample copy

Sleep Apnea Devices Market is expected to reach US$ 8,305.3 Mn by 2025
https://www.theinsightpartners.com/sample/TIPHE100000846/?utm_source=EINPressWire&utm_medium=10144

Sleep Aids Market Forecast to 2028 - Covid-19 Impact and Global Analysis
https://www.theinsightpartners.com/sample/TIPRE00004945/?utm_source=EINPressWire&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Press Release: https://www.theinsightpartners.com/pr/sleep-apnea-diagnostics-and-therapeutics-market
More Research: https://daulatguru.com/author/theinsightpartners/

Sameer Joshi
The Insight Partners
+91 96661 11581
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn